Holen Sie sich die Stockscreener-App
0.3245
0.73%
-0.0026
Schlusskurs vom Vortag:
$0.3271
Offen:
$0.3227
24-Stunden-Volumen:
688.15K
Relative Volume:
0.38
Marktkapitalisierung:
$4.94M
Einnahmen:
$486.00K
Nettoeinkommen (Verlust:
$-28.43M
KGV:
-0.1151
EPS:
-2.8189
Netto-Cashflow:
$-26.75M
1W Leistung:
-7.20%
1M Leistung:
-73.17%
6M Leistung:
-88.15%
1J Leistung:
-82.64%
1-Tages-Spanne:
$0.32
$0.3365
1-Wochen-Bereich:
$0.32
$0.3979
52-Wochen-Spanne:
$0.32
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3245 | 5.73M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.69 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
604.25 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.66 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.30 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
310.83 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Is VYNE Therapeutics Inc. stock entering bullish territory2025 Market Sentiment & Daily Price Action Insights - Newser
VYNE Therapeutics Inc. stock volume spike explained2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser
Will breakout in VYNE Therapeutics Inc. lead to full recoveryJuly 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Why VYNE Therapeutics Inc. is moving todayJuly 2025 Setups & Risk Managed Investment Signals - Newser
What to do if you’re stuck in VYNE Therapeutics Inc.Quarterly Trade Review & Risk Controlled Daily Plans - Newser
Is it time to cut losses on VYNE Therapeutics Inc.July 2025 Gainers & Low Drawdown Investment Strategies - Newser
Price action breakdown for VYNE Therapeutics Inc.Volume Spike & AI Driven Price Forecasts - Newser
What MACD and RSI say about VYNE Therapeutics Inc.2025 Biggest Moves & Short-Term Trading Alerts - Newser
Will VYNE Therapeutics Inc. stock recover after recent drop2025 Market WrapUp & Daily Price Action Insights - Newser
Technical analysis overview for VYNE Therapeutics Inc. stockTrade Volume Report & Capital Efficiency Focused Strategies - Newser
VYNE Therapeutics Inc. Approaches Psychological Resistance Level2025 Major Catalysts & Weekly Consistent Profit Watchlists - newsimpact.co.kr
VYNE Therapeutics Q2 2025 Earnings: EPS Beats, Revenue Falls Short of Expectations - AInvest
VYNE Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Elliott Wave Theory Predicts Pullback in VYNE Therapeutics Inc.Buy Signal & Accurate Trade Setup Notifications - newsyoung.net
Chart based exit strategy for VYNE Therapeutics Inc.Swing Trade & Smart Investment Allocation Tips - Newser
Is VYNE Therapeutics Inc. reversing from oversold territoryQuarterly Investment Review & Daily Oversold Bounce Ideas - Newser
Does VYNE Therapeutics Inc. show high probability of reboundJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Tools to assess VYNE Therapeutics Inc.’s risk profileJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - Newser
How to read the order book for VYNE Therapeutics Inc.2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - Newser
Is VYNE Therapeutics Inc. trending in predictive chart modelsMarket Trend Report & Growth Focused Entry Reports - Newser
Is VYNE Therapeutics Inc. stock technically oversold2025 Momentum Check & Low Volatility Stock Recommendations - mustnews.co.kr
Is VYNE Therapeutics Inc. stock poised for growth2025 Trade Ideas & Fast Gain Swing Alerts - Newser
How Resilient Is VYNE Therapeutics Inc. Stock During Economic DownturnsTake Profit & Fast Entry High Yield Tips - Newser
VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Up 526.7% in July - Defense World
Risk vs reward if holding onto VYNE Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - Newser
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates - MSN
VYNE Stock Update: VYNE Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
VYNE 2025 Q2 Earnings Losses Narrow Despite Sharp Revenue Drop - AInvest
VYNE Therapeutics Reports Q2 2025 Financials and Updates - TipRanks
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability - TipRanks
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Is There Enough Volume to Lift VYNE Therapeutics Inc.Earnings Overview Report & Real-Time Chart Breakout Alerts - 선데이타임즈
VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year - TipRanks
VYNE Therapeutics Directors Resign Amid Financial Updates - TipRanks
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update | VYNE Stock News - GuruFocus
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):